A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma

Background. Patients with recurrent synovial sarcomas have few options for systemic therapy. Since they express large amounts of endogenous CT (cancer testis) antigens such as NY-ESO-1, we investigated the clinical activity of single agent anti-CTLA4 antibody ipilimumab in patients with advanced or...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Maki, Robert G., Jungbluth, Achim A., Gnjatic, Sacha, Schwartz, Gary K., D'Adamo, David R., Keohan, Mary Louise, Wagner, Michael J., Scheu, Kelly, Chiu, Rita, Ritter, Erika, Kachel, Jennifer, Lowy, Israel, Old, Lloyd J., Ritter, Gerd
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2013
Konular:
Clinical Study
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3608267/
https://ncbi.nlm.nih.gov/pubmed/23554566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/168145
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller